A varying presentation of refractory supra ventricular tachycardia in a newborn: A rare and unusual case report Authors: Aditi Rawat, Mahaveer S. Lakra, Sagar A. R. Karotkar, Bhavana Lakhkar, Amar Taksande Published: 2026 ABSTRACT ABSTRACTConduction abnormalities in neonates are not common and some arrhythmias may resolve spontaneously, while refractory abnormalities may persist. Some rare arrhythmias may be associated with congestive cardiac failure (CCF) or shock, requiring immediate intervention. Most supraventricular tachycardias (SVT) respond to adenosine and are rarely refractory. If not managed properly, it may result in more complications, prolonged hospital stays, and mortality. Here, we are reporting the case of a 20-day-old baby who presented with poor feeding, respiratory distress, lethargy, and tachycardia. The heart rate was at 248 beats per minute, and the electrocardiogram showed a narrow QRS complex arrhythmia. The baby was diagnosed with arrhythmia with CCF and was loaded with adenosine. The baby did not respond to increasing subsequent adenosine doses, so the baby needed an amiodarone infusion, digoxin therapy, and cardioversion. The baby was successfully managed and discharged on tablet propranolol and syrup digoxin, which were discontinued at subsequent visits. Refractory arrhythmias are not a rare phenomenon and can be seen in neonates too, so any baby, if not responding to conventional treatment and adenosine, must be treated with second-line antiarrhythmic drugs. Introduction Supraventricular tachycardia is the most common arrhythmia found in infants, affecting up to 1 in 2500 babies. It arises in newborns with otherwise healthy hearts; however, it can also coexist with other congenital structural heart disease and other cardiac issues. Neonatal SVT in babies may not cause any symptoms, and some babies with the syndrome “grow out” of it. Rarely, newborns have the potential to suffer serious cardiac failure if extended bouts happen that might endanger life.[1] Neonatal SVT symptoms appear after delivery in bursts that can last anywhere from a few seconds to many hours. Many infants will appear generally sick, although they do not exhibit any particular symptoms. They might not be as alert as normal, look pale, eat poorly, or vomit. Symptoms might include heart flickers, shortness of breath, dizziness, and chest discomfort.[2] Most of the time, it is a benign condition and resolves spontaneously, but if it is not responding to vagal maneuvers, it may require second-line antiarrhythmic drugs, resuscitation, and cardioversion.[3] Vagal stimulation and adenosine, amiodarone, flecainide, and esmolol are very effective in reversing arrhythmias.[4] The challenge in neonates is to identify and treat refractory arrhythmias. Here, we are reporting a neonatal case of refractory supraventricular tachycardia having persistent pulmonary hypertension who presented with congestive cardiac failure (CCF), which was managed successfully with multiple antiarrhythmic drugs. Case Details A 2.9-kg male baby was born to a primigravida at 39.6 weeks of gestation by normal vaginal delivery. The baby cried immediately after birth and was shifted to its mother’s side. The baby accepted feeding well and passed stools and urine adequately. On day 20 of life, he developed a cough, fast breathing, and difficulty in feeding. On examination, the baby was irritable with mild respiratory distress; the HR was 248 beats per minute, the RR was 68 beats per minute, the Spo2 was 96% with oxygen, the blood pressure was 64/42 mm Hg, and the CRT was 3 seconds. All peripheral pulses were well felt and had good volume. On the cardiovascular system examination, S1 and S2 were heard, and no murmur was found. Respiratory system examination showed bilateral air entry with rhonchi and basal crypts. On per abdominal examination, the liver measured 4 cm below the costal margin with a span of 5 cm with no splenomegaly. The laboratory parameters were hemoglobin 15.4 g/dl, TLC 11600 per cum/dl, hematocrit 46.8 mg/dl, C-reactive protein 25 mg/dl, serum ionic calcium 4.8 mg, sodium 136 meq/dl, and potassium 5.7 meq/dl. The serum magnesium and thyroid profiles were normal. The chest x-ray was normal. An ECG was performed, which showed right axis deviation with a heart rate of 226 narrow QRS complex arrhythmia, suggestive of supraventricular tachycardia, as shown in Figure 1. Echocardiogram of the baby showing narrow QRS complex having a heart rate of 226 beat/minute with absent P wave with right axis deviation, suggestive of supraventricular tachycardia Echocardiography showed no underlying structural heart disease but showed evidence of pulmonary persistent hypertension in the form of dilatation of the right ventricle, straightening of the interventricular septum, and tricuspid regurgitation with jet flow [Figure 2]. The pulmonary pressure was moderately superasystemic, and bidirectional flow was seen over the patent foramen ovale. Evidence of pulmonary persistent hypertension in the form of straightening of the interventricular septum and dilatation of the right ventricle The patient was immediately started on intravenous fluid and stabilized. After the initial maneuver, the baby was given an injection of adenosine 0.25 mg intravascular by flush method, followed immediately by a normal saline bolus. Despite the two doses of 0.2 mg/kg and 0.3 mg/kg of adenosine, respectively, it could not be reversed as the arrhythmia persisted, so the baby was given injections of digoxin and amiodarone along with cardioversion. Baby responded to amiodarone, and his heart rate came out to be 140 beats per minute. The shock, CCF, and sepsis parts were managed with good antibiotic coverage and injection of sildenafil, milrinone, and lasix. The amiodarone and digoxin were continued for 5-7 days during the hospital stay. The final diagnosis of septicemia with persistent pulmonary hypertension, refractory supraventricular tachycardia, and congestive cardiac failure with shock was made. The baby was managed successfully and was discharged on digoxin and propranolol. At subsequent follow-up, he was found to have a normal heart rate with complete resolution of symptoms. The SVT, which was resistant to adenosine, was managed with digoxin and amiodarone infusions and cardioversion successfully with a good team effort. Discussion The most common causes of arrhythmia in neonates are atrial tachycardia, AV re-entrant phenomenon, and reciprocal AV entrant arrhythmia.[5] The baby may present with tachycardia, tachypnoea, diaphoresis, cyanosis, pallor, irritability, and poor weight gain. The most common etiology is fever, viral infection, and underlying structural heart defects, which are documented in 15% of the cases only. CCF may be associated with around 35% of the cases and is most common under the age of 4 months. The mechanism of tachycardia also varies under 1 year of age. In 5% of the cases, it is AV nodal; in 80% of cases, it is reciprocating tachycardia, and in 15% atrial tachycardia.[2] The presence of tachycardia, tachypnoea, palpable liver 3 cm below the costal margin, and the presence of rhonchi or mild crepitation with decreased perfusion are the manifestations of CCF in neonates. Cardiomegaly may or may not be there, depending upon the type of heart lesions.[6] If an arrhythmia is not responding to a single drug, then digoxin alone or amiodarone, or a combination of both, may be useful for refractory tachycardia.[7] Intravenous verapamil should be avoided as it may result in refractory hypotension. When the fetal and neonatal tachycardia are not responding to routine digoxin, then amiodarone will be very helpful in refractory tachycardia and heart failures.[8] The main treatment for SVT in neonates depends upon symptoms, the presence of shock, CCF, and whether the baby is cardiorespiratory stable or not. The first-line treatment involves the use of adenosine, as vagal maneuvers are generally not recommended in newborns. Other treatment modalities include immediate control by aborting arrhythmias with adenosine or cardioversion, use of amiodarone or flecainide, and avoidance of further relapse with esmolol or amiodarone. Similar cases were also reported by McDowell M et al.[9] reported SVT in a 4-week-old baby, but the baby responded to adenosine by single-syringe method technique. Mecarini D et al.[10] also reported a case of recurrent SVT leading to necrotizing enterocolitis due to gut ischemia due to hampering of blood flow and gut hypoperfusion. In our index case, there was no gut involvement, and no organ damage was seen. Our patient was followed up at one month and two months of age. The baby was stable, showing weight gain and a regular heart rhythm. Conclusion Neonatal arrhythmia, however, is a rare entity in newborns, but refractory arrhythmias can be encountered in routine practice. Early suspicion and identification are more important as the vagal maneuver and adenosine may not work, and early advanced treatment can be lifesaving for refractory arrhythmias. The knowledge of this entity in newborns and infants is important from an emergency management point of view for all the treating physicians and neonatologists. Take home message for primary physicians It is very difficult to diagnose arrhythmias in newborn babies as, most of the time, the symptoms are non-specific, and electrocardiography cannot be traced because of the difficulty of recording ECG at the peripheral level. The presentation may be different from that of adult and pediatric patients and may be undiagnosed and untreated. It should be differentiated from sinus tachycardia. All the possible underlying causes, along with cardiac association, must be overlooked, and full cardiac evaluation is a must. Initially, all babies presenting with supraventricular arrhythmia must be given an injection of adenosine as a quick bolus. We should see the response and look for the hemodynamic instability of the baby. If still not aborted, then second-line drugs must be considered along with cardioversion or if the facility is not available, the baby must be referred to a well-equipped center with all in-house facilities. Novelty of the case Moreover, the staff is also not trained in taking ECG in periphery, and the echocardiography facility is also limited. Seeing the varying presentation and subtle features in newborn, this entity must be kept in mind, and the baby must be evaluated. The proper diagnosis and timely referral are the key to management. So a primary physician must keep in mind the varying presentation of refractory arrhythmia in newborn also from perspectives of management and better neonatal outcome. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Conflicts of interest There are no conflicts of interest.